Dyslipidemia, Insulin Resistance, Ectopic Lipid Accumulation, and Vascular Function in Resistance to Thyroid Hormone β

Abstract Purpose In resistance to thyroid hormone due to mutations in thyroid hormone receptor β, peripheral tissues are variably refractory to the action of circulating thyroid hormones. We evaluated parameters contributing to atherosclerotic risk in this disorder. Methods We measured low-density lipoprotein cholesterol (LDL-C), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), nonesterified fatty acids (NEFA), intrahepatic lipid (IHL) and intramyocellular lipid (IMCL), Homeostasis-model assessment of insulin resistance (HOMA-IR), augmentation index (AIx) and pulse wave velocity (PWV), flow-mediated dilatation, and carotid intima-media thickness (cIMT) in an unselected, genetically confirmed cohort of adult RTHβ patients (n = 27-77) and compared these with measurements in healthy subjects (up to n = 100) and thyrotoxic patients (n = 40). Results Resistance to thyroid hormone beta (RTHβ) patients exhibited higher LDL-C (P = 0.008) and TG (P = 0.002) and lower HDL-C concentrations (P = 0.015 × 10–2) than control subjects, with LDL-C being higher than in thyrotoxic patients with comparable hyperthyroxinemia. Proprotein convertase subtilisin/kexin 9 (P = 0.002) and apolipoprotein B (P = 0.0009) levels were reduced in thyrotoxic patients but not lower in RTHβ patients or control subjects. Intrahepatic lipid (P = 0.02 × 10–4), IMCL (P = 0.002), HOMA-IR (P = 0.01 × 10–2), and NEFA (P = 0.04 × 10–6) were significantly higher in RTHβ patients than control subjects. Flow-mediated dilatation was increased (P = 0.04) but cIMT (P = 0.71), PWV P = 0.81), and AIx (P = 0.95) were unaltered in RTHβ patients. Conclusions We have documented mixed dyslipidemia with hepatic and IMCL accumulation in RTHβ, suggesting that surveillance for these metabolic abnormalities is warranted. How they combine with enhanced endothelial function and unaltered vessel wall thickness and compliance to determine overall cardiometabolic risk in this disorder remains to be defined.

[1]  F. Wondisford,et al.  A Direct Comparison of Thyroid Hormone Receptor (THR) Protein Levels in Mice Provides Unexpected Insights into TH Action. , 2020, Thyroid : official journal of the American Thyroid Association.

[2]  B. Neuschwander‐Tetri,et al.  Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial , 2019, The Lancet.

[3]  C. Mantzoros,et al.  Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. , 2018, Thyroid : official journal of the American Thyroid Association.

[4]  O. Franco,et al.  Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study. , 2016, The Journal of clinical endocrinology and metabolism.

[5]  E. Fliers,et al.  The Hypercoagulable state in Hyperthyroidism is mediated via the Thyroid Hormone β Receptor pathway. , 2016, European journal of endocrinology.

[6]  P. Ladenson,et al.  Reductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver‐selective thyroid hormone receptor agonist eprotirome , 2015, Journal of internal medicine.

[7]  B. Angelin,et al.  Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans[S] , 2014, Journal of Lipid Research.

[8]  D. Dunger,et al.  Low circulating levels of IGF-1 in healthy adults are associated with reduced β-cell function, increased intramyocellular lipid, and enhanced fat utilization during fasting. , 2014, The Journal of clinical endocrinology and metabolism.

[9]  S. Refetoff,et al.  The syndromes of reduced sensitivity to thyroid hormone. , 2013, Biochimica et biophysica acta.

[10]  B. Goodpaster,et al.  Role of intramyocelluar lipids in human health , 2012, Trends in Endocrinology & Metabolism.

[11]  Henry Völzke,et al.  Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania. , 2012, Thyroid : official journal of the American Thyroid Association.

[12]  E. Rodríguez-Sánchez,et al.  Relationship between intima-media thickness of the common carotid artery and arterial stiffness in subjects with and without type 2 diabetes: a case-series report , 2011, Cardiovascular diabetology.

[13]  J. Rungby,et al.  Decreased lipid intermediate levels and lipid oxidation rates despite normal lipolysis in patients with hypothyroidism. , 2010, Thyroid : official journal of the American Thyroid Association.

[14]  K. Petersen,et al.  Resistance to thyroid hormone is associated with raised energy expenditure, muscle mitochondrial uncoupling, and hyperphagia. , 2010, The Journal of clinical investigation.

[15]  P. Park,et al.  Thyroid hormone-related regulation of gene expression in human fatty liver. , 2009, The Journal of clinical endocrinology and metabolism.

[16]  K. Aoyagi,et al.  Thyroid function is associated with carotid intima-media thickness in euthyroid subjects. , 2009, Atherosclerosis.

[17]  J. Lazarus,et al.  Augmentation index in resistance to thyroid hormone (RTH) , 2009, Clinical endocrinology.

[18]  M. Willingham,et al.  Distinct dysregulation of lipid metabolism by unliganded thyroid hormone receptor isoforms. , 2009, Molecular endocrinology.

[19]  S. O’Rahilly,et al.  Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. , 2009, The Journal of clinical investigation.

[20]  A. Kotronen,et al.  Fatty Liver: A Novel Component of the Metabolic Syndrome , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R. Sabit,et al.  Thyroid disease and vascular function. , 2007, Thyroid : official journal of the American Thyroid Association.

[22]  Yasmin,et al.  Isolated Systolic Hypertension Is Characterized by Increased Aortic Stiffness and Endothelial Dysfunction , 2007, Hypertension.

[23]  Thomas S. Scanlan,et al.  Rapid nongenomic actions of thyroid hormone , 2006, Proceedings of the National Academy of Sciences.

[24]  K. Sung,et al.  Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lpa levels according to thyroid function status. , 2004, Archives of medical research.

[25]  M. Emoto,et al.  Decrease in carotid intima‐media thickness in hypothyroid patients after normalization of thyroid function , 2003, Clinical endocrinology.

[26]  P. Ladenson,et al.  Hypothyroidism and atherosclerosis. , 2003, The Journal of clinical endocrinology and metabolism.

[27]  B. Biondi,et al.  Impact of Hyperthyroidism and Its Correction on Vascular Reactivity in Humans , 2001, Circulation.

[28]  D. Webb,et al.  Reproducibility of pulse wave velocity and augmentation index measured by pulse wave analysis , 1998, Journal of hypertension.

[29]  C. Marcocci,et al.  Do clinical manifestations of resistance to thyroid hormone correlate with the functional alteration of the corresponding mutant thyroid hormone-beta receptors? , 1995, The Journal of clinical endocrinology and metabolism.

[30]  R. Weiss,et al.  The syndromes of resistance to thyroid hormone. , 1993, Endocrine reviews.

[31]  V K Chatterjee,et al.  Thyroid hormone resistance syndrome. Inhibition of normal receptor function by mutant thyroid hormone receptors. , 1991, The Journal of clinical investigation.

[32]  G. Brabant,et al.  Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST. , 1990, The Journal of clinical endocrinology and metabolism.

[33]  G. Kahaly,et al.  Cardiac involvement in thyroid hormone resistance. , 2002, The Journal of clinical endocrinology and metabolism.

[34]  J. Oppenheimer,et al.  Functional relationship of thyroid hormone-induced lipogenesis, lipolysis, and thermogenesis in the rat. , 1991, The Journal of clinical investigation.

[35]  M. Taskinen,et al.  Lipoproteins, lipolytic enzymes, and hormonal status in hypothyroid women at different levels of substitution. , 1988, The Journal of clinical endocrinology and metabolism.